Vera Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 5.89 M | $298.21 M | -5.17% | 9.22% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 5.46 M | $276.60 M | 48.97% | 8.55% |
| BLACKROCK, INC. | 02/12/2026 | 4.83 M | $244.36 M | 13.62% | 7.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 4.06 M | $205.58 M | 11.49% | 6.36% |
| VANGUARD GROUP INC | 01/29/2026 | 3.57 M | $180.81 M | 11.90% | 5.59% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 3.43 M | $173.85 M | -14.77% | 5.38% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 3.07 M | $155.58 M | 9.42% | 4.81% |
| FMR LLC | 02/17/2026 | 2.89 M | $146.14 M | 1.50% | 4.52% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.82 M | $142.86 M | 100.00% | 4.42% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 2.79 M | $141.49 M | 0.00% | 4.38% |
| STATE STREET CORP | 02/13/2026 | 2.68 M | $135.54 M | 14.70% | 4.19% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 1.80 M | $91.15 M | 5.88% | 2.82% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.74 M | $88.03 M | 36.66% | 2.72% |
| BELLEVUE GROUP AG | 02/17/2026 | 1.70 M | $85.99 M | 100.00% | 2.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.44 M | $73.19 M | 9.33% | 2.26% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.39 M | $70.51 M | -3.25% | 2.18% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 1.31 M | $66.21 M | 100.00% | 2.05% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.22 M | $61.71 M | 2,217.23% | 1.91% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.12 M | $56.76 M | 47.75% | 1.76% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.00 M | $50.65 M | 35.62% | 1.57% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 869.68 K | $44.04 M | 71.50% | 1.36% |
| TRI LOCUM PARTNERS LP | 02/17/2026 | 805.69 K | $40.80 M | -32.31% | 1.26% |
| BRAIDWELL LP | 02/17/2026 | 784.74 K | $39.74 M | 66.00% | 1.23% |
| CITADEL ADVISORS LLC | 02/17/2026 | 777.49 K | $39.37 M | -51.87% | 1.22% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 732.70 K | $37.10 M | 3.43% | 1.15% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 702.20 K | $35.56 M | 100.00% | 1.10% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 694.32 K | $35.16 M | 41.56% | 1.09% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 653.80 K | $33.11 M | 21.98% | 1.02% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 601.77 K | $30.47 M | 69.74% | 0.94% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 568.58 K | $28.79 M | -7.91% | 0.89% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 550.00 K | $27.85 M | -27.63% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 518.86 K | $26.27 M | 11.39% | 0.81% |
| MORGAN STANLEY | 02/13/2026 | 499.67 K | $25.30 M | 82.01% | 0.78% |
| 02/17/2026 | 482.50 K | $24.43 M | 100.00% | 0.76% | |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 474.67 K | $24.04 M | 86.89% | 0.74% |
| NORTHERN TRUST CORP | 02/17/2026 | 473.22 K | $23.96 M | 2.59% | 0.74% |
| CANDRIAM S.C.A. | 04/30/2026 | 449.55 K | $22.77 M | 5.24% | 0.70% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 420.00 K | $21.27 M | 223.08% | 0.66% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/12/2026 | 418.96 K | $21.22 M | 0.62% | 0.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 378.06 K | $19.14 M | -18.07% | 0.59% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 02/17/2026 | 371.15 K | $18.80 M | 100.00% | 0.58% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 353.50 K | $17.90 M | 100.00% | 0.55% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 351.89 K | $17.82 M | -2.34% | 0.55% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 347.43 K | $17.59 M | -45.19% | 0.54% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 325.56 K | $16.49 M | 54.68% | 0.51% |
| BARCLAYS PLC | 02/13/2026 | 253.72 K | $12.85 M | 16.60% | 0.40% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/06/2026 | 252.46 K | $12.78 M | 100.00% | 0.40% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 250.00 K | $12.66 M | -17.58% | 0.39% |
| ALPHABET INC. | 02/13/2026 | 241.26 K | $12.22 M | 0.00% | 0.38% |
| NUVEEN, LLC | 02/12/2026 | 227.08 K | $11.50 M | -28.52% | 0.36% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Vera Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 263 institutional investors and hedge funds held shares of Vera Therapeutics Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 1.05 M
Candriam S.C.A.: 475,335
Nuveen, LLC: 398,602
UBS Group AG: 187,887
Bank of New York Mellon Corp: 179,354
CenterBook Partners LP: 97,003
115.91% of Vera Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 83.66 M shares in the last 24 months. This purchase volume represents approximately $3.26 B in transactions.